Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer.
暂无分享,去创建一个
Alexandra Rink | Cynthia Ménard | Andrew Bayley | Charles Catton | Alejandro Berlin | C. Ménard | C. Catton | P. Warde | A. Berlin | P. Chung | A. Bayley | J. Murgić | Padraig Warde | Peter Chung | Anna Simeonov | A. Rink | A. Simeonov | Gerald O'Leary | Jure Murgic | Jessamine Abed | Jessamine Abed | G. O’Leary
[1] Ming Xu,et al. Towards Personalized Statistical Deformable Model and Hybrid Point Matching for Robust MR-TRUS Registration , 2016, IEEE Transactions on Medical Imaging.
[2] J. Bernhard,et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. , 2015, European urology.
[3] Deidre Batchelar,et al. A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants. , 2013, Brachytherapy.
[4] C. N. Coleman,et al. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner , 2004, Magnetic resonance in medicine.
[5] Deidre Batchelar,et al. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy. , 2013, Brachytherapy.
[6] Morikatsu Wada,et al. MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer , 2014, Journal of medical imaging and radiation oncology.
[7] Y. Yoshioka,et al. The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer , 2013, Journal of radiation research.
[8] D. Margolis,et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.
[9] A. Evans,et al. MR-guided prostate biopsy for planning of focal salvage after radiation therapy. , 2015, Radiology.
[10] H. Hricak,et al. Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy. , 2012, International journal of radiation oncology, biology, physics.
[11] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[12] M. Zelefsky,et al. Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients. , 2013, Brachytherapy.
[13] S J Damore,et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[14] A. Fiorentino,et al. In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy. , 2013, International journal of radiation oncology, biology, physics.
[15] G. S. Gustafson,et al. The Role of Needle Trauma in the Development of Urinary Toxicity Following Prostate High Dose Rate (HDR) Brachytherapy , 2007 .
[16] M. Kattan,et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.
[17] C. N. Coleman,et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. , 2004, International journal of radiation oncology, biology, physics.
[18] Paul Schellhammer,et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.
[19] J. Pouliot,et al. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. , 2012, Brachytherapy.
[20] Oguz Akin,et al. Imaging prostate cancer , 2002 .
[21] Liying Zhang,et al. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] M. Zelefsky,et al. How to select the optimal therapy for early-stage prostate cancer. , 2012, Critical reviews in oncology/hematology.
[23] J. Montie,et al. Functional anatomy of the prostate: implications for treatment planning. , 2005, International journal of radiation oncology, biology, physics.
[24] J. Witjes,et al. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. , 2015, European urology.
[25] F. Foroudi,et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Amita Shukla-Dave,et al. Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI. , 2010, International journal of radiation oncology, biology, physics.
[27] J Alfred Witjes,et al. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.
[28] J. Hendry,et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. , 2012, International journal of radiation oncology, biology, physics.
[29] Deidre Batchelar,et al. Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning. , 2014, Brachytherapy.
[30] J. Pouliot,et al. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. , 2008, International journal of radiation oncology, biology, physics.
[31] J. Pouliot,et al. Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose. , 2014, Practical radiation oncology.
[32] Mary Feng,et al. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. , 2010, International journal of radiation oncology, biology, physics.
[33] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[34] Kemal Tuncali,et al. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. , 2015, Radiology.